⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18338825 | 1.00 | — | — | |
| SCHEMBL16795113 | 0.79 | MEN1 (0.34) | — | |
| SCHEMBL18128809 | 0.79 | MEN1 (0.34) | — | |
| SCHEMBL16792283 | 0.69 | — | — | |
| SCHEMBL18339066 | 0.69 | — | — | |
| SCHEMBL619591 | 0.64 | ADRA2A (0.58) | — | |
| SCHEMBL619590 | 0.64 | ADRA2A (0.58) | — | |
| SCHEMBL31600623 | 0.64 | ADRA2A (0.58) | — | |
| SCHEMBL21572709 | 0.62 | PLAU (0.39) | — | |
| SCHEMBL14190582 | 0.62 | HSD17B10 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3080129-B1 | IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2020-06-03 | — | — | EP | disclosed |
| US-9714251-B2 | Imidazotriazine derivatives as modulators of TNF activity | UCB BIOPHARMA SPRL (BE) | 2017-07-25 | — | — | US | disclosed |
| US-20160376276-A1 | Imidazotriazine Derivatives as Modulators of TNF Activity | UCB BIOPHARMA SPRL (BE) | 2016-12-29 | — | — | US | disclosed |
| EP-3080129-A1 | IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SPRL (BE) | 2016-10-19 | — | — | EP | disclosed |
| WO-2015086503-A1 | IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2015-06-18 | — | — | WO | disclosed |